Acute and chronic administration of the cannabinoid receptor agonist CP 55,940 attenuates tumor-evoked hyperalgesia.
about
Use of Animal Models in Understanding Cancer-induced Bone PainCannabinoids as therapeutic agents in cancer: current status and future implicationsMechanism of cancer pain.The role of peripheral cannabinoid receptors type 1 in rats with visceral hypersensitivity induced by chronic restraint stress.Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids.The neurobiology of cancer pain.Increasing 2-arachidonoyl glycerol signaling in the periphery attenuates mechanical hyperalgesia in a model of bone cancer pain.Carbonic anhydrase-8 regulates inflammatory pain by inhibiting the ITPR1-cytosolic free calcium pathway.CB1 and CB2 receptor agonists promote analgesia through synergy in a murine model of tumor painThe endocannabinoid system and cancer: therapeutic implication.The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applicationsEnhanced excitability of small dorsal root ganglion neurons in rats with bone cancer pain.Tumor-evoked sensitization of C nociceptors: a role for endothelinThe analgesic potential of cannabinoids.A decrease in anandamide signaling contributes to the maintenance of cutaneous mechanical hyperalgesia in a model of bone cancer painThe non-selective cannabinoid receptor agonist WIN 55,212-2 attenuates responses of C-fiber nociceptors in a murine model of cancer painAnalysis of nociception, sex and peripheral nerve innervation in the TMEV animal model of multiple sclerosis.The cannabinoid receptor agonist, WIN 55, 212-2, attenuates tumor-evoked hyperalgesia through peripheral mechanismsTumor-evoked hyperalgesia and sensitization of nociceptive dorsal horn neurons in a murine model of cancer pain.Peripheral cannabinoids attenuate carcinoma-induced nociception in miceNew insights of nociceptor sensitization in bone cancer pain.Behavioral Characterization of κ Opioid Receptor Agonist Spiradoline and Cannabinoid Receptor Agonist CP55940 Mixtures in Rats.Spinal and peripheral analgesic effects of the CB2 cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain.Mouse models for studying pain in sickle disease: effects of strain, age, and acuteness.Dose-dependent teratogenicity of the synthetic cannabinoid CP-55,940 in mice.Pharmacological effects of cannabinoids on the reference and working memory functions in mice.Depletion of capsaicin-sensitive afferents prevents lamina-dependent increases in spinal N-methyl-D-aspartate receptor subunit 1 expression and phosphorylation associated with thermal hyperalgesia in neuropathic rats.
P2860
Q26785501-12C279E0-9DAD-4BB4-97A7-A0FE6E0961D8Q26866298-61F24D36-D03E-4037-9125-A94AF159ACA9Q33953901-835587BB-8287-454A-BEAB-EC97F4BEAEB8Q34028431-B1F6D4CD-3A99-4D02-BAC5-0A75983DA235Q34033859-74211546-560D-49F8-86C8-C8817B9B6234Q34167635-24F4D893-49E5-4BE6-87B4-574DCB7CB6CFQ35013497-494C273E-9E46-4ACB-81EF-91BEF5042236Q35142140-BAC2D41F-8A1A-465F-8370-89F3991583B9Q35162945-4C0D8DC2-9AD0-4028-A528-6AFEFD83846DQ35193299-83E2ACC7-2801-46A8-8582-302AA593FC69Q35921090-C5F53746-EF3B-4F87-9A7F-27B335CF7357Q36048793-47E3A684-81DE-4E86-BF55-36D0F9D36DDEQ36956936-3D03684D-40DD-4FD4-827C-251687003DF7Q37057325-09D1F868-6893-4B62-BC4E-CBEE26670D88Q37067266-010F9C29-F51A-45AD-B035-35F5E389FF4AQ37120771-7FC14CAF-0293-4CFD-A8BD-D4FFD7648325Q37169940-C82019CE-DAB0-40DC-934B-66094BDDAC5AQ37182268-D62A8EDF-64C9-4F88-82C4-FE84191CF59EQ37239670-74C44643-9544-4B25-B189-7097FF72B787Q37407417-B82AF345-298F-427E-ACC1-E5B6A752DEAEQ38303224-C387AAA1-E1A4-4629-8A36-C78E9A3EA529Q39141647-77FD1888-8823-4D5E-8B35-174E84B8C5DAQ39727048-D6C38F61-086E-4FC2-B53D-328EC903D47BQ41996084-8C2F478B-EE0A-4051-A76D-E24ED07F3CB8Q42633075-88A426B2-6E70-45B7-9CB7-8349B3ACC756Q44457651-4F6D59B4-071A-448A-B85B-FF10E6AD30D4Q46953284-90D42168-5865-4B3C-AEC7-EC885A333F69
P2860
Acute and chronic administration of the cannabinoid receptor agonist CP 55,940 attenuates tumor-evoked hyperalgesia.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Acute and chronic administrati ...... tes tumor-evoked hyperalgesia.
@ast
Acute and chronic administrati ...... tes tumor-evoked hyperalgesia.
@en
type
label
Acute and chronic administrati ...... tes tumor-evoked hyperalgesia.
@ast
Acute and chronic administrati ...... tes tumor-evoked hyperalgesia.
@en
prefLabel
Acute and chronic administrati ...... tes tumor-evoked hyperalgesia.
@ast
Acute and chronic administrati ...... tes tumor-evoked hyperalgesia.
@en
P2093
P2860
P921
P1476
Acute and chronic administrati ...... tes tumor-evoked hyperalgesia.
@en
P2093
Darryl T Hamamoto
Donald A Simone
Subhalakshmi Giridharagopalan
P2860
P356
10.1016/J.EJPHAR.2006.11.062
P407
P577
2006-12-09T00:00:00Z